Collectively, our data provided new insights on the characteristics and functions of CAF subtypes in NSCLC and suggested the critical roles of POSTN+ CAFs in immune suppression and tumour progression, indicating that they may be promising targets for the treatment of NSCLC. This evidence concerns the gene POSTN and neoplasm.